113 related articles for article (PubMed ID: 3333527)
1. Why has the primary prevention of myocardial infarction in the treatment of hypertension been so elusive?
Cruickshank JM
J Hum Hypertens; 1987 Sep; 1(2):73-81. PubMed ID: 3333527
[TBL] [Abstract][Full Text] [Related]
2. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
Oparil S; Bakir SE
Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
[TBL] [Abstract][Full Text] [Related]
3. Low mortality from all causes, including myocardial infarction, in well-controlled hypertensives treated with a beta-blocker plus other antihypertensives.
Cruickshank JM; Pennert K; Sörman AE; Thorp JM; Zacharias FM; Zacharias FJ
J Hypertens; 1987 Aug; 5(4):489-98. PubMed ID: 3668249
[TBL] [Abstract][Full Text] [Related]
4. The future of antihypertensive treatment.
Israili ZH; Hernández-Hernández R; Valasco M
Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
[TBL] [Abstract][Full Text] [Related]
5. Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades.
Almgren T; Persson B; Wilhelmsen L; Rosengren A; Andersson OK
J Intern Med; 2005 Jun; 257(6):496-502. PubMed ID: 15910553
[TBL] [Abstract][Full Text] [Related]
6. The Hypertension Optimal Treatment study and the importance of lowering blood pressure.
Hansson L
J Hypertens Suppl; 1999 Feb; 17(1):S9-13. PubMed ID: 10340838
[TBL] [Abstract][Full Text] [Related]
7. [Treatment in the primary prevention of stroke--still not fully used option].
Widimský J
Cas Lek Cesk; 2004; 143(10):657-63. PubMed ID: 15584613
[TBL] [Abstract][Full Text] [Related]
8. Epidemiological and cost implications of antihypertensive treatment for the prevention of cardiovascular disease.
Grimm RH
J Hum Hypertens; 1989 Dec; 3 Suppl 2():55-60; discussion 60-1. PubMed ID: 2514265
[TBL] [Abstract][Full Text] [Related]
9. Isolated systolic hypertension in the elderly: lessons from clinical trials and future directions.
Black HR
J Hypertens Suppl; 1999 Dec; 17(5):S49-54. PubMed ID: 10706327
[TBL] [Abstract][Full Text] [Related]
10. Impact of blood pressure control on cardiovascular events in 26,512 Japanese hypertensive patients: the Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study, a prospective nationwide observational study.
Shimamoto K; Fujita T; Ito S; Naritomi H; Ogihara T; Shimada K; Tanaka H; Yoshiike N;
Hypertens Res; 2008 Mar; 31(3):469-78. PubMed ID: 18497466
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
[TBL] [Abstract][Full Text] [Related]
12. [Retrospective studies and prospects of therapy for hypertension].
Maisch B; Brilla C; Kruse T; Noll B; Bethge C
Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
[TBL] [Abstract][Full Text] [Related]
13. The HOPE Study (Heart Outcomes Prevention Evaluation).
Sleight P
J Renin Angiotensin Aldosterone Syst; 2000 Mar; 1(1):18-20. PubMed ID: 11967789
[TBL] [Abstract][Full Text] [Related]
14. Blood pressure and coronary heart disease: a review of the evidence.
Lawes CM; Bennett DA; Lewington S; Rodgers A
Semin Vasc Med; 2002 Nov; 2(4):355-68. PubMed ID: 16222626
[TBL] [Abstract][Full Text] [Related]
15. [Cardiovascular risk stratification. Systolic, diastolic or pulse pressure?].
Pede S; Lombardo M
Ital Heart J Suppl; 2001 Apr; 2(4):356-8. PubMed ID: 19397006
[TBL] [Abstract][Full Text] [Related]
16. Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.
Leenen FH
Can J Cardiol; 2004 Aug; 20 Suppl B():77B-82B. PubMed ID: 15309209
[TBL] [Abstract][Full Text] [Related]
17. Primary prevention with beta-blockade in patients with hypertension: review of results and clinical implications.
Wikstrand J
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S64-75. PubMed ID: 11527139
[TBL] [Abstract][Full Text] [Related]
18. Reduced total mortality and death from myocardial infarction and stroke in moderate/severe hypertensives treated with "Tenormin" (atenolol).
Cruickshank JM
Drugs Exp Clin Res; 1990; 16(3):133-6. PubMed ID: 2387213
[TBL] [Abstract][Full Text] [Related]
19. Long-term safety of antihypertensive therapy.
Grossman E; Messerli FH
Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
[TBL] [Abstract][Full Text] [Related]
20. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
